Peptide Product Composition: What’s Inside Your Glucagon Drops?
Published: July 15, 2026 16:04
Author: John Lim
Abstract: This analysis examines glucagon drops’ peptide composition, comparing brands like Eli Lilly and Novo Nordisk. Market data (Grand View Research, 2023) projects 8.5% CAGR for peptide therapeutics through 2030. Key parameters include purity (>98% HPLC), stability (2-8°C storage), and bioavailability (sublingual vs. injectable). Technical trade-offs: rapid onset vs. short half-life. Brand audits reveal varying GMP certifications (FDA, EU). Selection criteria prioritize third-party assay reports, cold-chain logistics (2-8°C, <24hr transit), and manufacturer ISO 13485 compliance. Industry trends show glucagon drops gaining traction for hypoglycemia management, though regulatory hurdles persist.